bioRxivCancer BiologyPreprint
Hypoxia and epithelial to mesenchymal transition pathways are enriched in bladder tumor epithelium adjacent to tertiary lymphoid structures
Kartik SachdevaiD, Priyanka YolmoiD, Abdulhameed Abdulhamed, Gwenaëlle ConseiliD, Sadaf RahimiiD, David Monty BermaniD, Kathrin TyryshkiniD, Roger LiiD, D. Robert SiemensiD, Madhuri KotiiD
Abstract
Formation of tertiary lymphoid structures (TLS) within the bladder microenvironment because of chronic mucosal inflammation has been associated with variable clinical outcomes. While the immune cell composition and functional states of TLS have been characterized in both non-invasive and muscle-invasive bladder tumors, the TLS-adjacent tumor epithelial compartments remain poorly characterized. Evaluation of a 16-gene TLS signature in treatment-naive tumor bulk RNA sequencing profiles from 283 non-muscle invasive bladder tumors, from patients treated with Bacillus Calmette-Guerin (BCG) immunotherapy, and 348 muscle-invasive bladder tumors from patients treated with immune checkpoint inhibitor therapy revealed overlapping enrichment of immune exhaustion pathways. High TLS gene expression scores correlated with upregulation of immune exhaustion, hypoxia, and epithelial-to-mesenchymal transition (EMT) pathways in tumors from both cohorts. Spatial whole transcriptomic analysis of tumor sections with high TLS density, revealed enrichment of genes associated with EMT, angiogenesis, extracellular matrix remodeling, and B cell receptor signaling pathways in tumor epithelial regions adjacent to TLS, whereas those distant from TLS exhibited enrichment of IFN-{gamma}, TNF-/NF-{kappa}B, p53, and metabolic pathways. Multiplex immunofluorescence further identified co-localization of exhausted immune cell populations within the core and periphery of peri-tumoral TLS. These findings indicate that a pro-tumorigenic microenvironment associated with disease progression in bladder cancer exists within peri-tumoral TLS and potentially a factor underlying contrasting therapeutic associations potentially driven by live microbial versus targeted immunomodulatory therapy in NMIBC and MIBC.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Carcinogen induced expansion of atypical B cells and pre-treatment tumor adjacent tertiary lymphoid structures associate with poor response to BCG in non-muscle invasive bladder cancer
- The landscape of tertiary lymphoid structures in endometrial cancer revealed through harmonized multi-level transcriptomics
Marta Requesens, Koen Brummel, … Marco de Bruyn·bioRxiv·Aug 20, 2025
- The HLA-E/NKG2A axis identifies a therapeutic vulnerability in BCG-unresponsive bladder cancer
Bérengère Salomé, Haocheng Yu, … Amir Horowitz·bioRxiv·Sep 2, 2024
- Tumor Immunity Microenvironment-based classifications of bladder cancer for enhancing cancer immunotherapy
- NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer
B. Salome, J. P. Sfakianos, … Mariath·bioRxiv·Mar 4, 2022
- Tertiary lymphoid structures are associated with enhanced macrophage activation, immune checkpoint expression and predict outcome in cervical cancer.
L. Gorvel, M. Panouillot, … D. Olive·bioRxiv·Aug 17, 2023